ThirtyFiveBio aims to treat gastrointestinal cancer by targeting a so-called orphan receptor called GPR35. The biotech startup is revealing its science at the American Association of Cancer Research annual meeting.
Fewer people are dying from cancer due to advances in research, screening and treatment, according to a new report. In order for the death rate to fall further, U.S. oncologists must prioritize personalized treatment and addressing social determinants of health, an expert argued.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Results from the study, performed on more than 10,000 women by Johns Hopkins and Geisinger Health, were presented at the American Association for Cancer Research's 2020 meeting, which is virtual this year due to Covid-19.
Among 29 patients, the drug - designed for patients who become resistant to TRK inhibitors like Vitrakvi - showed a 34 percent response rate, according to Phase I data.
Memorial Sloan Kettering Chief Medical Officer Jose Baselga resigned Thursday following publication of a New York Times-ProPublica investigation of his financial relationships with drugmakers.
Here's how the life science research organizations are taking the news that Trump's budget proposal will chop off $5.8 billion in funding the federal government provides to the National Institutes of Health.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.